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In light of the recent retraction of the *New England Journal of Medicine* article entitled "Cardiovascular Disease, Drug Therapy, and Mortality in COVID-19" (Mehra et al., full citation provided below), the authors would like to remove the following statement, which appeared on page 2, under the heading **Cardiovascular Disease and COVID-19**:

"An observational database of the Surgical Outcomes Collaborative registry, which comprised of 8910 hospitalized COVID-19 patients from 169 hospitals in Asia, Europe, and North America, found that an age greater than 65, and diagnosis of history coronary artery disease, heart failure, and/or cardiac arrhythmias were independently associated with increased risk of in-hospital death, with 5.8% (*n* = 515) of this cohort dying in the hospital \[[17](https://urldefense.proofpoint.com/v2/url?u=https-3A__link.springer.com_article_10.1007_s11912-2D020-2D00945-2D4-23ref-2DCR17&d=DwMGaQ&c=UXmaowRpu5bLSLEQRunJ2z-YIUZuUoa9Rw_x449Hd_Y&r=IZajxiOGIUHemJkj6z0AUFnoHT-gGu0AjUqTdd33Avo&m=y1zMGf1OSP6w6dmUniczpT1Mx9i7TALQOypLmdlnDhY&s=CzSIOjA0CxZffeH-gfEtYdo_yZBaa-t-wUmQErkjoxU&e=)\]."

Given the existence of other epidemiological studies cited in this review, the authors believe the removal of this statement does not significantly alter the impact and objectives of this article.
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